Dr. Oyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2102 Harrisburg Pike
Lancaster, PA 17604Phone+1 717-544-7154Fax+1 717-544-7153
Summary
- I am a Medical Oncologist serving as the founding Medical Director of the Ann B. Barhshinger Cancer Institute Penn Medicine Lancaster General in Lancaster, Pennsylvania. I am active with ASCO and ACCC.
Education & Training
Drexel University College of Medicine/Hahnemann University HospitalFellowship, Hematology and Medical Oncology, 1984 - 1986- Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1980 - 1984
Georgetown University School of MedicineClass of 1980
Certifications & Licensure
CA State Medical License 1992 - 2025
PA State Medical License 1982 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Apr 15
- A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage Start of enrollment: 2009 Jul 16
- Join now to see all
Publications & Presentations
PubMed
- 340 citationsCD8 + T cells contribute to survival in patients with COVID-19 and hematologic cancer.Erin Bange, Nicholas Han, Paul Wileyto, Justin Kim, Sigrid Gouma
Nature Medicine. 2021-05-20 - 20 citationsDigital Health Applications in Oncology: An Opportunity to Seize.Ravi B Parikh, Karen M Basen-Enquist, Cathy Bradley, Deborah Estrin, Mia Levy
Journal of the National Cancer Institute. 2022-10-06 - 17 citationsDPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical ImplementationLisa A. Varughese, Kelsey S. Lau-Min, Christine Cambareri, Nevena Damjanov, Ryan Massa
Pharmacotherapy. 2020-11-01
Press Mentions
Extending the Reach of Proton TherapyMay 29th, 2024- Doctors See Both Setbacks, Advances in Breast Cancer CareOctober 4th, 2022
- Rucaparib Is Effective in Maintenance Treatment for Ovarian CancerJune 8th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
